Edition:
United States

Prima BioMed Ltd (PRR.AX)

PRR.AX on Australia Stock Exchange

0.04AUD
26 Jul 2016
Change (% chg)

$-0.00 (-2.38%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
685,221
Avg. Vol
1,412,707
52-wk High
$0.07
52-wk Low
$0.04

PRR.AX

Chart for PRR.AX

About

Prima BioMed Limited is an Australia-based biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. The Company focuses on cancer immunotherapy research. The Company's main pipeline of products is based on the LAG-3 immune control mechanism, which plays a... (more)
No analyst recommendations are available for PRR.AX.

Overall

Beta: 1.20
Market Cap(Mil.): $86.59
Shares Outstanding(Mil.): 2,061.63
Dividend: --
Yield (%): --

Financials

  PRR.AX Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -0.04 -- --
ROI: -215.40 -5.86 14.35
ROE: -257.59 -4.70 15.56

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Sadif Analytics Prime
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.